Goodpasture syndrome overview

Title

https://https://www.youtube.com/watch?v=vAX2UMA8Oek%7C350}}

Goodpasture syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Goodpasture syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Goodpasture syndrome overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Goodpasture syndrome overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Goodpasture syndrome overview
CDC on Goodpasture syndrome overview
Goodpasture syndrome overview in the news
Blogs on Goodpasture syndrome overview
Directions to Hospitals Treating Goodpasture syndrome
Risk calculators and risk factors for Goodpasture syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Goodpasture’s disease is a rare condition characterised by rapid destruction of the kidneys and hemorrhaging of the lungs.

Although many diseases can present with these symptoms, the name Goodpasture’s syndrome is usually reserved for the autoimmune disease produced when the patient’s immune system attacks cells presenting the Goodpasture antigen, which are found in the kidney and lung, causing damage to these organs.